Arrowhead Research | ARWR - Passività Correnti





Passività Correnti Cambiamento Data
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Anika Therapeutics USD 20.97M 942K 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
Merck USD 26.94B 1.38B 2026-03
Moderna USD 2.4B 408M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xencor USD 73.46M 22.45M 2026-03